Related Experiment Video
Updated: May 12, 2025

An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
Type 3 resistant starch prepared from euryale ferox alleviated the obesity symptoms via gut microbiota regulation
Yutong Zhang1, Jiayi Huang2, Yajuan Qin2
1Sanya Research Institute, Chinese Academy of Tropical Agriculture Sciences, National Key Laboratory for Tropical Crop Breeding, Sanya 572025, Hainan, China; Spice and Beverage Research Institute, Chinese Academy of Tropical Agricultural Sciences, National Center of Important Tropical Crops Engineering and Technology Research, Key Laboratory of Processing Suitability and Quality Control of the Special Tropical Crops of Hainan Province, Wanning 571533, Hainan, China; Jiangxi Deshang Technology Group Co., Ltd., Jiangxi Deshang Pharmaceutical Co., Ltd., Zhangshu 331299, Jiangxi, China; College of Food Science, Northeast Agricultural University, Harbin 150030, China.
Abstract:
The type 3 resistant starch (RS3) was obtained from euryale ferox through enzymolysis-autoclaving. The effects of euryale ferox RS3 (ERS) on the body weight, lipid metabolism, inflammatory response, and gut microbiota composition of golden hamsters administered a high-fat diet were determined to assess the potential role of ERS in inhibiting obesity. The purified ERS was in the B + V-type crystal form, which has a great anti-enzymatic structure. Additionally, ERS may promote the growth of beneficial gut microbiota including norank_f_Muribaculaceae and Ruminococcus, while it can inhibit the growth of the gut microbiota including Allobaculum, thus alleviating symptoms of weight gain, fat accumulation, oxidative stress, chronic low-grade inflammation, and liver injury. The above findings laid a theoretical foundation for the application of ERS in specific foods to prevent obesity.
Related Concept Videos
Hormonal Regulation
Irritable Bowel Syndrome III: Medical and Nursing Management
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Regulation of Food Intake

